Drugs & medicalClass II

Aurobindo Pharma USA Inc. recalls Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279…

CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

Read the official notice →
Date
2022-11-02
Country
United States
Brand
Aurobindo Pharma
Product
Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279…
Classification
Class II
Units
Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Aurobindo Pharma recalls

  1. 2023-09-27
  2. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A., NDC 0378-1270-93

    Failed dissolution specifications - results obtained were below spec average.

    FDA · DrugAurobindo Pharma USA Inc.USA nationwideOfficial notice →
  3. 2023-08-30
  4. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279…

    cGMP deviations: Batch was released prior to approval.

    FDA · DrugAurobindo Pharma USA Inc.USA nationwideOfficial notice →
  5. 2023-05-31
  6. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200…

    Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.

    FDA · DrugAurobindo Pharma USA Inc.The recalled product was distributed to one Retail Distributor (Walgreens) who…Official notice →
  7. 2022-04-20
  8. US
    Drugs & medicalClass III

    Aurobindo Pharma USA Inc. recalls Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics…

    Subpotent Drug: Out of Specification results for Assay

    FDA · DrugAurobindo Pharma USA Inc.Nationwide in the USA.Official notice →
  9. 2022-02-23
  10. US
  11. 2022-02-02
  12. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05

    Superpotent and Failed Tablet/Capsule Specifications

    FDA · DrugAurobindo Pharma USA Inc.Nationwide in the USOfficial notice →
All 15 Aurobindo Pharma recalls →

Other drugs & medical recalls in the United States

  1. 2022-11-02
  2. US
    Drugs & medicalClass II

    Siemens Medical Solutions USA, Inc recalls ARTIS pheno, Interventional fluoroscopic x-ray system, Model No. 10849000

    Siemens has become aware of three potential software issues with ARTIS pheno systems with software version VE10B. This may lead to a hazardous situation for patients if treatment cannot be continued on the system and…

    FDA · DeviceSiemens Medical Solutions USA, IncDomestic distribution nationwide. Foreign distribution worldwide.Official notice →
  3. US
    Drugs & medicalClass II

    ZOLL Circulation, Inc. recalls AutoPulse Li-ion Battery used on the AutoPulse Resuscitation System Model 100. used as an adjunct to manual CPR

    Due to increase in Li-Ion Battery failures

    FDA · DeviceZOLL Circulation, Inc.U.S.: AK, AL, AR, AZ, CA, CO, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA,…Official notice →
  4. US
    Drugs & medicalClass I

    Exela Pharma Sciences LLC recalls 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only,…

    Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration

    FDA · DrugExela Pharma Sciences LLCNationwide within the United StatesOfficial notice →
  5. US
    Drugs & medicalClass II

    AuroMedics Pharma LLC recalls Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279…

    Subpotent Drug: Out of specification for assay

    FDA · DrugAuroMedics Pharma LLCNationwide in the USAOfficial notice →
  6. US
    Drugs & medicalClass I

    Golden State Medical Supply Inc. recalls Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated,…

    Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets

    FDA · DrugGolden State Medical Supply Inc.USA NationwideOfficial notice →
  7. US
    Drugs & medicalClass II

    VistaPharm, Inc. recalls Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC…

    cGMP Deviations: Out of specification for assay of one of the preservative ingredients.

    FDA · DrugVistaPharm, Inc.USA NationwideOfficial notice →
See all drugs & medical recalls →